Janus Henderson Group
MYOV

Janus Henderson Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Janus Henderson Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,177,158
Closed -$31.7M – 2801
2022
Q4 		$31.7M Sell
1,177,158
-6,730,524
-85% -$177M 0.02% 469
2022
Q3 		$142M Buy
7,907,682
+2,458,575
+45% +$39.3M 0.05% 290
2022
Q2 		$67.7M Sell
5,449,107
-123,797
-2% -$1.37M 0.05% 314
2022
Q1 		$74.2M Buy
5,572,904
+45,440
+0.8% +$609K 0.04% 394
2021
Q4 		$86.1M Sell
5,527,464
-151,586
-3% -$2.89M 0.04% 388
2021
Q3 		$127M Buy
5,679,050
+258,033
+5% +$5.67M 0.06% 316
2021
Q2 		$123M Buy
5,421,017
+181,735
+3% +$3.82M 0.05% 331
2021
Q1 		$108M Buy
5,239,282
+140,967
+3% +$3.21M 0.05% 353
2020
Q4 		$141M Buy
5,098,315
+1,134,832
+29% +$22.1M 0.07% 291
2020
Q3 		$55.7M Sell
3,963,483
-67,717
-2% -$1.26M 0.03% 472
2020
Q2 		$83.1M Sell
4,031,200
-682,289
-14% -$9.28M 0.05% 358
2020
Q1 		$35.6M Sell
4,713,489
-6,138
-0.1% -$68.8K 0.02% 538
2019
Q4 		$73.2M Buy
4,719,627
+91,843
+2% +$926K 0.04% 472
2019
Q3 		$24.1M Buy
4,627,784
+277,449
+6% +$2.06M 0.01% 782
2019
Q2 		$39.4M Buy
4,350,335
+1,843,943
+74% +$27.5M 0.02% 639
2019
Q1 		$59.8M Sell
2,506,392
-57,674
-2% -$1.18M 0.03% 536
2018
Q4 		$42.1M Buy
2,564,066
+38,873
+2% +$766K 0.03% 581
2018
Q3 		$67M Buy
2,525,193
+1,401,796
+125% +$31.7M 0.04% 506
2018
Q2 		$25.7M Buy
+1,123,397
New +$24.5M 0.01% 737

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Janus Henderson Group's MYOV Position: Q1 2023 in Review

Janus Henderson Group sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 1,177,158 shares — an estimated $31.7M sold.

Janus Henderson Group first reported a position in MYOV in Q2 2018 and held it in 19 quarters. The position peaked at $142M in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Janus Henderson Group reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Janus Henderson Group sold 1,177,158 Myovant Sciences Ltd. shares in Q1 2023, an estimated $31.7M.
  • Janus Henderson Group first reported a position in Myovant Sciences Ltd. in Q2 2018 and held it in 19 quarters.
  • Janus Henderson Group's Myovant Sciences Ltd. position peaked at $142M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.